Paloma Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Paloma Partners's RGEN Position: Q4 2024 in Review
Paloma Partners sold out of Repligen (RGEN) in Q4 2024, closing a stake of 6,932 shares — an estimated $1.03M sold.
Paloma Partners first reported a position in RGEN in Q2 2015 and held it in 14 quarters. The position peaked at $13M in Q2 2020. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.
- Paloma Partners reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
- Paloma Partners sold 6,932 Repligen shares in Q4 2024, an estimated $1.03M.
- Paloma Partners first reported a position in Repligen in Q2 2015 and held it in 14 quarters.
- Paloma Partners's Repligen position peaked at $13M in Q2 2020.
- 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.
Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.